Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,580.00
+3.70 (0.23%)
Jul 31, 2026, 3:30 PM IST
Aurobindo Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 909,212 | 757,598 | 674,020 | 637,941 | 303,575 | 391,729 | |
Market Cap Growth | 35.19% | 12.40% | 5.66% | 110.14% | -22.50% | -24.14% |
Enterprise Value | 883,684 | 746,546 | 689,676 | 632,994 | 283,996 | 394,408 |
Last Close Price | 1580.20 | 1304.40 | 1156.16 | 1084.68 | 513.88 | 653.35 |
PE Ratio | 26.19 | 21.62 | 19.34 | 20.11 | 15.75 | 14.79 |
Forward PE | 20.36 | 18.02 | 15.91 | 17.77 | 12.19 | 12.83 |
PS Ratio | 2.70 | 2.25 | 2.13 | 2.20 | 1.22 | 1.67 |
PB Ratio | 2.40 | 2.00 | 2.07 | 2.14 | 1.13 | 1.59 |
P/TBV Ratio | 2.79 | 2.32 | 2.36 | 2.46 | 1.31 | 1.85 |
P/FCF Ratio | 32.01 | 26.67 | 34.45 | - | - | 13.22 |
P/OCF Ratio | 16.45 | 13.71 | 17.17 | 26.20 | 12.72 | 7.81 |
PEG Ratio | 1.25 | 1.53 | 1.36 | 0.78 | 1.63 | 2.09 |
EV/Sales Ratio | 2.63 | 2.22 | 2.17 | 2.18 | 1.14 | 1.68 |
EV/EBITDA Ratio | 12.89 | 10.89 | 10.64 | 10.98 | 7.81 | 9.15 |
EV/EBIT Ratio | 17.40 | 14.70 | 13.71 | 14.41 | 11.31 | 11.93 |
EV/FCF Ratio | 31.11 | 26.28 | 35.25 | - | - | 13.31 |
Debt / Equity Ratio | 0.21 | 0.21 | 0.25 | 0.22 | 0.20 | 0.12 |
Debt / EBITDA Ratio | 1.18 | 1.18 | 1.26 | 1.14 | 1.43 | 0.65 |
Debt / FCF Ratio | 2.84 | 2.84 | 4.22 | - | - | 0.96 |
Net Debt / Equity Ratio | -0.07 | -0.07 | 0.00 | 0.01 | -0.04 | -0.07 |
Net Debt / EBITDA Ratio | -0.37 | -0.37 | 0.01 | 0.06 | -0.26 | -0.40 |
Net Debt / FCF Ratio | -0.90 | -0.90 | 0.03 | -0.93 | 55.51 | -0.58 |
Asset Turnover | 0.62 | 0.62 | 0.67 | 0.68 | 0.67 | 0.69 |
Inventory Turnover | 1.19 | 1.19 | 1.33 | 1.42 | 1.45 | 1.26 |
Quick Ratio | 0.98 | 0.98 | 0.99 | 0.96 | 0.98 | 1.10 |
Current Ratio | 1.81 | 1.81 | 1.85 | 1.98 | 1.88 | 2.22 |
Return on Equity (ROE) | 9.93% | 9.93% | 11.15% | 11.18% | 7.50% | 11.39% |
Return on Assets (ROA) | 5.86% | 5.86% | 6.63% | 6.46% | 4.25% | 6.10% |
Return on Invested Capital (ROIC) | 10.05% | 10.23% | 11.01% | 11.33% | 7.60% | 11.66% |
Return on Capital Employed (ROCE) | 12.50% | 12.50% | 14.30% | 13.40% | 8.80% | 12.80% |
Earnings Yield | 3.85% | 4.63% | 5.17% | 4.97% | 6.35% | 6.76% |
FCF Yield | 3.12% | 3.75% | 2.90% | -0.54% | -0.06% | 7.56% |
Dividend Yield | 0.51% | - | - | 0.41% | 0.58% | 1.38% |
Payout Ratio | 6.63% | 6.63% | 0.03% | 8.31% | 22.80% | 9.96% |
Buyback Yield / Dilution | 0.35% | 0.35% | 0.52% | - | - | - |
Total Shareholder Return | 0.86% | 0.35% | 0.52% | 0.41% | 0.58% | 1.38% |